Joslin Diabetes Center

Dr. Aiello is an Associate Clinical Professor of Ophthalmology at Harvard Medical School and the Founder and Chief of the Beetham Eye Unit of Joslin Diabetes Center in Boston. He holds a concurrent appointment as Chief of Ophthalmology in Surgery at New England Deaconess Hospital. He serves as President of the New England Ophthalmological Society and as a member of the National Diabetes Scientific Advisory Committee, Diabetes 2000, of the American Academy of Ophthalmology. A graduate of Harvard College and the Boston University School of Medicine, Dr. Aiello began his career as a physician in the Navy. He has spent the majority of his medical career doing research in diabetic eye disease and the use of lasers in medicine and biology. He has done extensive work on the use of lasers for the treatment of diabetic retinopathy and has made considerable contributions to this field. He has been following a number of families with VHL in the Boston area for some thirty years. As a medical adviser to the Alliance he shares with us his expertise in the appli-cation of laser to retinal diseases, and his richness of exper-ience with von Hippel-Lindau in these patients. His son, Lloyd Paul Aiello, has recently joined the Beetham Eye Unit as an ophthalmologist.

Dr. Jacobson is Senior Vice President for Strategic Initiatives at Joslin Diabetes Center and heads the Section on Behavioral and Mental Health Research in the Joslin Research Division and the Mental Health Unit in the Joslin Clinic. Dr. Jacobson is also Professor of Psychiatry at Harvard Medical School. He received his medical degree at the University of Chicago Medical School and completed residency training in psychiatry at Massachusetts General Hospital (MGH). Prior to coming to Joslin he was Unit Chief, Mental Health Department, Bunker Hill Health Center of MGH. He is the recipient of numerous awards and honors, such as election to the Academy of Behavioral Medicine Research. He has served as scientific consultant to the National Institute of Mental Health, and has also been the principal investigator of several large research grants.

Dr. Caballero is a Clinical Investigator, Staff Endocrinologist and Associate Medical Director of Professional Education at Joslin Diabetes Center, as well as an Assistant Professor of Medicine at Harvard Medical School. He is also the Director of the Joslin Latino Diabetes Initiative. He is a tutor of the culturally competent care module at Harvard Medical School. Dr. Caballero received his medical degree from the National University of Mexico Medical School, where he was awarded the Gabino Barreda Medal for being the top student in his program. He completed his residency in Internal Medicine and a fellowship in Endocrinology at the National Institute of Nutrition in Mexico. In addition, he completed a fellowship program in Endocrinology and Metabolism at the Lahey Clinic, Beth Israel Deaconess Medical Center, Joslin Diabetes Center and the Program on Clinical Effectiveness at the Harvard School of Public Health.

Dr. Doria is an Investigator in the Section on Epidemiology and Genetics as well as Director of the Genetics Core at Joslin Diabetes Center. He is also an Associate Professor of Medicine at Harvard Medical School and an Associate Professor in the Department of Epidemiology at the Harvard School of Public Health. He received his medical degree and his doctorate in endocrinology and metabolism from the University of Padua in Italy, and did a fellowship at Joslin Diabetes Center. Prior to coming back to Joslin as Investigator, he was a Senior Lecturer/Honorary Consultant in Endocrinology and Diabetes at Guy's Hospital and the University of London in Great Britain.

John Zrebiec, a social worker and diabetes educator, is an associate director at the Joslin Diabetes Center in Boston and a lecturer in the department of psychiatry at Harvard Medical School.

Dr. Goldfine is an Associate Professor in Medicine at Harvard Medical School and Head of Clinical Research at the Joslin Diabetes Center. Dr. Goldfine received her M.D. from the University of Pennsylvania School of Medicine, and completed residency training at the University of Massachusetts Medical Center. She completed a fellowship in diabetes and endocrinology at Joslin before joining the staff of the Center.

Dr. Kulkarni is a Principle Investigator at the Joslin Diabetes Center, Assistant Professor of Medicine and a Faculty Member of the BBS Graduate Program at Harvard Medical School. Dr Kulkarni graduated with MD and PhD degrees from St. John's Medical College and the Royal Postgraduate Medical School, University of London, England. While working on his doctoral thesis on regulatory peptides modulating islet function in Prof. Steve Bloom's laboratory in England, Dr Kulkarni trained in the Diabetes Unit at Hammersmith Hospital in London. He moved to Boston, obtained the F32 National Research Scholarship Award (NIH), and completed a Post-Doctoral Fellowship in the laboratory of Prof. C. Ronald Kahn. Subsequently, he received the K08 Clinician Scientist Development Award (NIH) and Best Presentation Award by a K08 Awardee; he is the recipient of the 2007 Endocrine Society Ernst Oppenheimer Laureate Award for Outstanding Work by a Young Investigator and was elected to the American Society for Clinical Investigation in April 2007. Dr. Kulkarni has been on the Joslin Staff and Harvard Medical School Faculty since 1999, and currently serves on the Editorial Boards of Journal of Clinical Investigation, Diabetes, and J of Endocrinology.

Prior to joining Downer & Company, Ms. Ossikine was a quantitative financial analyst at Grantham, Mayo, Van Otterloo & Co., where her responsibilities included fundamental corporate analysis, quantitative strategy design, and portfolio construction. Earlier in her professional career, she was a financial information technology intern at UBS Warburg and Business Manager of a medical technology startup company.

Frances H. Miller is Of Counsel practicing in Nutter's Healthcare group. For more than twenty years Fran has been a professor at Boston University School of Law, where she teaches courses on trusts and estates, medical care and legal institutions, antitrust in the health sector, family law, and estate planning. She is also a professor at the university's School of Public Health and a professor of healthcare management at the School of Management. In 1989, the university awarded her with its highest teaching honor, the Metcalf Cup for Excellence in Teaching. Fran chairs the Massachusetts Health Facilities Appeals Board and has served as a member for the past two decades. She is a board member of the Massachusetts Health Data Consortium, a trustee of the Joslin Diabetes Center, a member of the Partners HealthCare Institutional Review Board, and a former commissioner of the Massachusetts Rate Setting Commission. In 1993, she served as a consultant to the White House Task Force on Healthcare Reform, as a member of the working group on malpractice and tort reform. A former Kellogg Foundation fellow and twice a Fulbright scholar, Fran has written widely for law reviews and medical journals, focusing on healthcare policy issues, tax planning, and family and inheritance law. She has also been a contributor to two PBS television series, "This is My Will" and "Fiscal Fitness." Fran has served the American Bar Association as a member of the Special Committee on Medical Professional Liability, the Task Force on Criminal Antitrust Enforcement in the Health Field, and the Coordinating Group on Bioethics and the Law.

Steven N. Kane was co-founder, Chairman and CEO of Gamesville of Watertown, Massachusetts, the leading Internet database marketing and interactive entertainment destination. Kane co-founded Gamesville in 1995 and oversaw all sales, marketing, product development and finance functions. Gamesville was acquired by Lycos, Inc. in November 1999. Gamesville was regularly amongst the 50 largest circulation web sites of any kind (as measured by Media Metrix) and was consistently in the top 10 sites for "stickiness," or frequency and duration of user sessions. Recognized for its highly innovative and valuable consumer data mining, profiling and targeting technologies - as well as its unique massively-multiplayer, real-time mass-appeal games which delivered a highly desirable 70% female, average age 34 demographic - the company became a profitable concern in 1997, and was highly accretive to Lycos Inc.'s earnings immediately upon consummation of the merger. Prior to Gamesville, Kane was a principal in, Elkay Products, Inc. of Shrewsbury, MA, the global developer, manufacturer and distributor of precision clinical and research laboratory consumables. At Elkay, Kane was responsible for all sales, marketing and information technology functions, including the company's substantial, key supplier relationships with Baxter International, Fisher Scientific, CMS, Owens & Minor and other global laboratory and hospital supply giants, as well as the company's close and lucrative OEM relationships with DuPont, Behring Diagnostics and other original equipment laboratory automation developers. In addition, Kane oversaw Elkay's cutting edge and essential EDI (Electronic Data Interchange) systems, which accounted for nearly 50% of the company's revenues. In April 1995, Elkay was acquired by The CIT Group Inc., and the company is now part of the Kendall division of Tyco International. Currently, Kane is founder, Chairman and CEO of GameLogic of Waltham, Massachusetts. Kane is also an Overseer of the Joslin Diabetes Center, the world's most respected facility for the study and treatment of diabetes.. Kane is a graduate of New York University and Phillips Academy Andover.